MethylDetect Looks to Leverage High-Resolution Melt Tech for Oncology Assay Development full story at: https://www.genomeweb.com/pcr/methyldetect-looks-leverage-high-resolution-melt-tech-oncology-assay-development?utm_source=Sailthru&utm_medium=email&utm_campaign=GWDN%20Fri%20PM%202019-01-25&utm_term=GW%20Daily%20News%20Bulletin#.XEwyFy2ZMc0
WHEN: 1 NOVEMBER14.00-18.00 WHERE: SAV VÆRKET, ÅRHUS, Søren Nymarks Vej 8A, 8270 Højbjerg FOR MORE INFO visit: https://mgra08.wixsite.com/scaleupdenmarkfinale
Interview about what we do, methylation biomarkers, our current product, technology (MS-HRM) and future IVD (in-vitro diagnostic) plans. see more at: https://biopeople.eu/news/show/september-profile-methyldetect/
We are one of the sponsors and will exhibit at 4BIO Summit: Europe, 27th-28th Nov 2018, Rotterdam, Netherlands for more info: http://www.global-engage.com/event/4bio/
For the next year we will be developing or business with the advicers from the Europe’s leading seen accelerator Methyl Detect
We will be at the Danish IP Fair on May 9th, with the intention to meet anyone interested in learning, and possibly using, our MS-HRM and cancer biomarker IP. There are all kinds of opportunities that we are open to discussion on. For example: Can you use MS-HRM in your own R&D? Would MS-HRM assays add value…